The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...

Pomdoctor Limited ("Pomdoctor" or the "Company") , a leading online medical services platform for chronic diseases in China, today announced a strategic upgrade centered on the core track of ...

Since its inception, artificial intelligence (AI) has been developed to mimic the adaptation and self-organization of living organisms or biological ...

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients worldwide, today announced completion of ...

If the rest of 2026 continues in this vein, we may look back on January and February as the moment the sector recognised that ...

A narrative review examines how generative AI tools such as large language models and vision-language models could assist precision oncology by interpreting genomic data, matching patients to clinical ...

The pharmaceutical and biotech sectors have seen a flurry of executive movement this month, with leadership changes spanning global giants, clinical-stage biotechs, and specialist pharma companies ...

Experts examine MFN pricing, the Great Healthcare Plan, ACA subsidies, PBM reform, and CMS talks in 2026. Lindsay Bealor ...

Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.

Peter Staley at CROI 2026 on defending 45 years of HIV progress: how clinicians, payers, and advocates can resist—quietly or publicly—and why it matters.

The new treatment uses the unique biology of the cancer itself to guide radiotherapy delivery, even in tumors that are in motion.

Nanomedicine is rapidly transforming the landscape of cancer treatment through the development of advanced drug-delivery carriers. Despite notable progress ...